- Home
- ATER vs APRE Comparison
ATER vs APRE Comparison
Compare ATER & APRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATER
- APRE
- Stock Information
- Founded
- ATER 2014
- APRE 2006
- Country
- ATER United States
- APRE United States
- Employees
- ATER N/A
- APRE N/A
- Industry
- ATER Home Furnishings
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ATER Consumer Discretionary
- APRE Health Care
- Exchange
- ATER Nasdaq
- APRE Nasdaq
- Market Cap
- ATER 10.3M
- APRE 8.3M
- IPO Year
- ATER N/A
- APRE 2019
- Fundamental
- Price
- ATER $1.07
- APRE N/A
- Analyst Decision
- ATER
- APRE Strong Buy
- Analyst Count
- ATER 0
- APRE 1
- Target Price
- ATER N/A
- APRE $20.00
- AVG Volume (30 Days)
- ATER 130.3K
- APRE 56.8K
- Earning Date
- ATER 11-10-2025
- APRE 11-06-2025
- Dividend Yield
- ATER N/A
- APRE N/A
- EPS Growth
- ATER N/A
- APRE N/A
- EPS
- ATER N/A
- APRE N/A
- Revenue
- ATER $85,668,000.00
- APRE $841,012.00
- Revenue This Year
- ATER N/A
- APRE N/A
- Revenue Next Year
- ATER $7.48
- APRE N/A
- P/E Ratio
- ATER N/A
- APRE N/A
- Revenue Growth
- ATER N/A
- APRE N/A
- 52 Week Low
- ATER $0.90
- APRE $1.37
- 52 Week High
- ATER $3.50
- APRE $5.01
- Technical
- Relative Strength Index (RSI)
- ATER 48.70
- APRE 51.13
- Support Level
- ATER $1.04
- APRE $1.40
- Resistance Level
- ATER $1.12
- APRE $1.53
- Average True Range (ATR)
- ATER 0.08
- APRE 0.08
- MACD
- ATER -0.00
- APRE 0.01
- Stochastic Oscillator
- ATER 20.00
- APRE 65.66
About ATER Aterian Inc.
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operates brands, including HomeLabs, Squatty Potty, Healing Solutions, PurSteam, and others. The company generates revenue through the online sales of various consumer products that are sold online.
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.